Westpfalz-Klinikum

Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO) (2021) Hugo C, Weihprecht H, Banas B, Schröppel B, Jank S, Arns W, Schenker P, et al. Journal article After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy (2020) Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, et al. Journal article Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ vertical bar Pancreas registry (2019) Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N, Vowinkel T, et al. Journal article Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al. Journal article Implementation of Current ENETS Guidelines for Surgery of Small (2cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry (2019) Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N, Vowinkel T, et al. Journal article Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study (2019) Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, et al. Journal article Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients (2018) Roellig C, Kramer M, Gabrecht M, Haenel MH, Herbst R, Kaiser U, Schmitz N, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia (2016) Mueller-Tidow C, Tschanter P, Roellig C, Thiede C, Koschmieder A, Stelljes M, Koschmieder S, et al. Journal article Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article